SRRK (scholarrock.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Scholar Rock, Inc. (SRRK)

Scholar Rock is developing neurological pharmaceuticals through alliances with global scientific centers, which accelerates the validation of treatments for muscle wasting. This daily price chart reflects this progress, with the metric currently at 20.23. The business relies on creating antibodies for individuals with SMA, utilizing government grants. Market protection is ensured by patents for a unique tissue growth stimulation system.

SRRK Scholar Rock Inc.: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar Scholar Rock, Inc. (SRRK)

- rega lan prakiraan konsensus rega:
Bagan rega Scholar Rock|SRRK - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar Scholar Rock Corp|SRRK - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Scholar Rock|SRRK - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku scholarrock.com|SRRK - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Scholar Rock|SRRK - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Scholar Rock Corp|SRRK - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Scholar Rock Corp|SRRK - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Scholar Rock
Analisis wiwitan perusahaan:Scholar Rock - SRRK
Produk asli Scholar Rock Corp

The specifics of Scholar Rock (SRRK), related to biosource supply risks and the complexity of global research, render its market valuation volatile. By analyzing the market-to-book ratio, an investor compares current capitalization with tangible assets, which allows them to filter out market noise and determine the fair value of the business relative to its equity to identify a safe entry point.

Pesaing utama

JAZZ: Rasio Nilai Pasar marang Nilai Buku|CYTK (cytokinetics.com) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku PTC Therapeutics PTCT|Kapitalisasi Pasar marang Aset Bersih Centessa Pharmaceuticals plc|Dyne Pharma (DYN) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Edgewise Corp (EWTX)|Rasio Kapitalisasi Pasar marang Nilai Buku RAPP (Rapport Therapeutics, Inc.)|alumis.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Zevra Therapeutics, Inc. (ZVRA)|CTNM: Nilai Pasar marang Nilai Buku|LRMR (Larimar Pharma) - Rasio Nilai Pasar marang Nilai Buku|Capricor Therapeutics, Inc. (CAPR) - Rasio Kapitalisasi marang Aset Bersih|TRDA (Entrada Therapeutics) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku channeltherapeutics.com (PTHS)|MediciNova, Inc. (MNOV) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku SER (Serina Therapeutics Inc)|BTAI - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku ProMIS Neurosciences Inc. PMN|APUS (Apimeds) - Rasio Kapitalisasi Pasar marang Nilai Buku|AEON Biopharma (AEON) - Koefisien Nilai Pasar marang Nilai Buku|NLSP: Rasio Kapitalisasi marang Aset Bersih|BNOX (Bionomics) - Rasio Kapitalisasi Pasar marang Nilai Buku|HUGE - Rasio Nilai Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku RETA